Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $31.7B |
| FY2017, ended Dec 31, 2017 | $48.5B |
| FY2018, ended Dec 31, 2018 | $36.9B |
| FY2019, ended Dec 31, 2019 | $49.1B |
| FY2020, ended Dec 31, 2020 | $42.8B |
| FY2021, ended Dec 31, 2021 | $53.9B |
| FY2022, ended Dec 31, 2022 | $45.9B |
| FY2023, ended Dec 31, 2023 | $65.3B |
| FY2024, ended Dec 31, 2024 | $76.9B |
| FY2025, ended Dec 31, 2025 | $82.2B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $96.6B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $15.4B |
| FY2017, ended Dec 31, 2017 | $20.5B |
| FY2018, ended Dec 31, 2018 | $20.8B |
| FY2019, ended Dec 31, 2019 | $21.0B |
| FY2020, ended Dec 31, 2020 | $10.6B |
| FY2021, ended Dec 31, 2021 | $13.9B |
| FY2022, ended Dec 31, 2022 | $20.8B |
| FY2023, ended Dec 31, 2023 | $23.7B |
| FY2024, ended Dec 31, 2024 | $25.1B |
| FY2025, ended Dec 31, 2025 | $26.2B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $26.9B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $808M | $1.42B |
| FY2017, ended Dec 31, 2017 | $1.46B | $1.99B |
| FY2018, ended Dec 31, 2018 | $1.91B | $1.80B |
| FY2019, ended Dec 31, 2019 | $1.27B | $1.03B |
| FY2020, ended Dec 31, 2020 | −$267M | $1.50B |
| FY2021, ended Dec 31, 2021 | $1.10B | $994M |
| FY2022, ended Dec 31, 2022 | $2.36B | $2.03B |
| FY2023, ended Dec 31, 2023 | $3.08B | $2.72B |
| FY2024, ended Dec 31, 2024 | $2.38B | $2.00B |
| FY2025, ended Dec 31, 2025 | $2.60B | $2.61B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.59B | $3.13B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $858M |
| FY2017, ended Dec 31, 2017 | $383M |
| FY2018, ended Dec 31, 2018 | $316M |
| FY2019, ended Dec 31, 2019 | $225M |
| FY2020, ended Dec 31, 2020 | $877M |
| FY2021, ended Dec 31, 2021 | $1.39B |
| FY2022, ended Dec 31, 2022 | $507M |
| FY2023, ended Dec 31, 2023 | $338M |
| FY2024, ended Dec 31, 2024 | $396M |
| FY2025, ended Dec 31, 2025 | $358M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $462M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $8.51B |
| FY2017, ended Dec 31, 2017 | $8.24B |
| FY2018, ended Dec 31, 2018 | $9.35B |
| FY2019, ended Dec 31, 2019 | $247M |
| FY2020, ended Dec 31, 2020 | $143M |
| FY2021, ended Dec 31, 2021 | $135M |
| FY2022, ended Dec 31, 2022 | $92.0M |
| FY2023, ended Dec 31, 2023 | $56.0M |
| FY2024, ended Dec 31, 2024 | $55.0M |
| FY2025, ended Dec 31, 2025 | $23.0M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $23.0M |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 32.0% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 384M |
| FY2017, ended Dec 31, 2017 | 357M |
| FY2018, ended Dec 31, 2018 | 340M |
| FY2019, ended Dec 31, 2019 | 324M |
| FY2020, ended Dec 31, 2020 | 324M |
| FY2021, ended Dec 31, 2021 | 326M |
| FY2022, ended Dec 31, 2022 | 308M |
| FY2023, ended Dec 31, 2023 | 289M |
| FY2024, ended Dec 31, 2024 | 276M |
| FY2025, ended Dec 31, 2025 | 265M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 261M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $568M | $212M | $34.0M | $9.27B |
| FY2017, ended Dec 31, 2017 | $3.01B | $181M | $6.00M | — |
| FY2018, ended Dec 31, 2018 | $2.85B | $184M | $4.00M | — |
| FY2019, ended Dec 31, 2019 | $2.26B | $187M | $7.00M | — |
| FY2020, ended Dec 31, 2020 | $150M | $201M | $0 | — |
| FY2021, ended Dec 31, 2021 | $0 | $182M | $2.00M | — |
| FY2022, ended Dec 31, 2022 | $2.57B | $192M | $0 | — |
| FY2023, ended Dec 31, 2023 | $3.95B | $205M | $29.0M | — |
| FY2024, ended Dec 31, 2024 | $3.76B | $237M | $73.0M | — |
| FY2025, ended Dec 31, 2025 | $3.30B | $236M | $92.0M | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $3.62B | $249M | $100M | — |
Valuation
At current price- Market Cap
- $102B
- P/E
- 39.3×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.8×
- Price / Book
- n/m. Market cap / shareholders' equity
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $26.9B
- Revenue Growth YoY
- 4.7%
- Revenue CAGR 3Y
- 8.0%
- Revenue CAGR 5Y
- 19.9%
- EPS Growth YoY
- 8.8%
- Net Income Growth YoY
- 4.9%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 15.8%
- Net Margin
- 9.6%
- FCF Margin
- 11.6%
- Return on Equity
- n/m. Net income (TTM) / average equity
Earnings
Trailing 12 months- Net Income
- $2.59B
- EPS (diluted)
- $9.66
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- $4.25B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $462M
- Total Debt
- $23.0M
- Net Cash
- $439M
- Total Assets
- $28.1B
- Total Liabilities
- $32.6B
- Shareholders' Equity
- −$4.53B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $3.73B
- Capital Expenditure
- $596M
- Free Cash Flow
- $3.13B
Dividends and risk
Last 12 months- Dividend Yield
- 0.7%
- Dividend / Share
- $2.80
- Beta (5Y)
- 1.17
Every ratio is calculated from the company’s reported figures.